Jul 82026 Loss of the kinases TBK1 and IKKε sensitizes target cancer cells to T cell killing through an IFN-γ–mediated inflammatory death program TBK1 and IKKε protect cancer cells from inflammatory apoptosis induced by T cell–derived IFN-γ
